Sfoglia per Autore
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery.
2001 E. Mini; F. Grassi; P. Cherubino; S. Nobili; P. Periti
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma.
2001 A. Martoni; E. Mini; C. Pinto; S. Nobili; A. L. Gentile; P. Dentico; B. Angelelli; S. Scicolone; E. Piana; T. Mazzei
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1
2002 Mini E, Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Toffoli G, Jansen G, Peters GJ, Priest DG, Mazzei T
The role of thymidylate synthase (TS) expression in prognosis and outcome of 5-fluorouracil (5-FU)-based chemotherapy in patients (pts) with colorectal cancer (CC)
2002 Mini E.; Morganti M.; Napoli C.; Valanzano R.; Cianchi F.; Messerini A; Nobili S; Boddi V; Tonelli F; Cortesini C; Toffoli G; Mazzei T
Phase II study of oxaliplatin (OHP) and raltitrexed (RTX) in chemonaive and pretreated advanced colorectal cancer (ACRC) patients
2002 Martoni A.; Mini E.; Pinto C.; Gentile AL; Nobili S; Marino A; Dentico P; Angelelli B; Scicolone S; Piana E; Mazzei T
Analisi dell'espressione di geni coinvolti nella resistenza al 5-fluorouracile nel carcinoma colorettale
2002 Stefania Nobili
Sequence-dependent interactions between oxaliplatin (OHP) and 5-fluorouracil (5-FU) in human colon carcinoma cell lines
2002 Mazzei T.; Carotti S.; Landini I.; Caciagli B.; Nobili S.; Mini E
Biweekly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy
2003 Nobili S; Mazzocchi V; Del Buono S.; Scicolone S; Giglioni B; Mazzei T; Mini E
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines
2003 Landini I; Carotti S; Caciagli B; Morganti M; Napoli C; Nobili S; Giglioni B; Boddi V; Mazzei T; Mini E
Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT-11), infusional 5-fluorouracil/folinic acis (FU/FA) in patients (PTS) with metastatic colorectal cancer (MCRC) pretreated with CPT-11- or OHP-based CHT
2003 Mini E; Nobili S; Mazzocchi V; Del Buono S; Scicolone S; Giglioni B; Mazzei T
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT)
2003 Morganti M; Ciantelli M; Giglioni B; Nobili S.; Papi L.; Landini I.; Napoli C.; Valanzano R.; Cianchi F; Boddi V.; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Neurotoxicity in advanced colorectal cancer (ACRC) patients treated with three different oxaliplatin (OXA) regimens
2003 Gentile AL; Pinto C; Mini E; Nobili S; Di Fabio F; Mazzei T; Martoni A
OXALIPLATIN PLUS RALTITREXED IN THE TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL CANCER: A PHASE II STUDY
2003 A. MARTONI; E. MINI; C. PINTO; AL. GENTILE; S. NOBILI; P. DENTICO; A. MARINO; S. SCICOLONE; B. ANGELELLI; T. MAZZEI
Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients (pts) with metastatic colorectal cancer (MCRC) pretreated with CPT11- or OHP-based CHT
2004 Mini E.; Nobili S; Del Buono S; Mazzocchi V; Filippelli F; Giglioni B; Mazzei T
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients
2004 Morganti, M; Ciantelli, M; Giglioni, B; Putignano, Al; Nobili, S; Papi, L; Landini, I; Napoli, C; Valanzano, R; Cianchi, F; Boddi, V; Tonelli, F; Cortesini, C; Mazzei, T; Genuardi, M; Mini, E.
Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients (PTS) with metastatic colorectal cancer (MCRC) pretreated with CPT11- or OHP-based CHT.
2004 Nobili S; Del Buono S; Mazzocchi V; Filippelli F; Giglioni B; Mazzei T; Mini E
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients
2004 Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E.
Neurotoxicity of oxaliplatin (OXA) in advanced colorectal cancer (ACRC) chemotherapy: evaluation of three consecutive prospective studies
2004 Di Fabio F; Mini E; Gentile AL; Nobili S; Angelelli B; Giaquinta S; Rojas Llimpe FL; Pinto C;Mazzei T; Martoni A
Bimonthly chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients with metastatic colorectal cancer pretreated with CPT11- or OHP-based CHT
2004 Nobili S; Del Buono S; Mazzocchi V; Filippelli F; Checcacci D; Giglioni B; Mazzei T; Mini E
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study.
2004 R.Mazzanti;AL.Giallombardo;E.Mini;S.Nobili;B.Neri;U.Arena; P.Pantaleo;V.Fabbroni;M.Ghilardi;R.Gattai;L.Bandettini
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile